Polynucleotide kinase (EC 2.7.1.78).
Maunders
M J
MJ
Advanced Technologies (Cambridge) Ltd., Cambridge, UK.
D000818:Animals; D055162:Biocatalysis / Q000187:drug effects; D002412:Cations; D004247:DNA / Q000378:metabolism; D020536:Enzyme Activators / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004795:Enzyme Stability / Q000187:drug effects; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D008967:Molecular Biology / Q000379:methods*; D011116:Polynucleotide 5'-Hydroxyl-Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013379:Substrate Specificity / Q000187:drug effects; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013696:Temperature
D002412:Cations; D020536:Enzyme Activators; D004791:Enzyme Inhibitors; D013439:Sulfhydryl Reagents; D004247:DNA; D011116:Polynucleotide 5'-Hydroxyl-Kinase